ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 944

$567K Total Retail Price of All Prescriptions

Rank: 147 out of 944

381 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 381 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 381 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
FUROSEMIDE 458 421 1 6
LEVOTHYROXINE SODIUM 409 353 2 2
WARFARIN SODIUM 386 261 3 7
METOPROLOL TARTRATE 342 287 4 8
SIMVASTATIN 315 259 5 1
LISINOPRIL 311 272 6 3
LANTUS 239 213 7 46
AMLODIPINE BESYLATE 220 150 8 5
OMEPRAZOLE 204 168 9 4
GABAPENTIN 197 119 10 18
DIVALPROEX SODIUM 182 139 11 85
HYDROCODONE-ACETAMINOPHEN 176 152 S3 12 10
CITALOPRAM HBR 157 142 13 19
MIRTAZAPINE 155 144 14 35
DONEPEZIL HCL 146 146 15 24
LIDODERM 138 132 16 73
PREDNISONE 138 131 16 32
KLOR-CON M20 130 110 18 71
SERTRALINE HCL 130 110 18 23
PANTOPRAZOLE SODIUM 117 79 20 34
CARVEDILOL 110 98 21 30
FENTANYL 109 96 S2 22 57
OXYCODONE-ACETAMINOPHEN 106 99 S2 23 62
RISPERIDONE 101 67 24 78
POLYETHYLENE GLYCOL 3350 100 79 25 41
ATENOLOL 94 80 26 11
OXYBUTYNIN CHLORIDE ER 91 64 27 102
CLONIDINE HCL 89 79 28 67
NAMENDA 87 87 29 37
PRAVASTATIN SODIUM 81 65 30 17
METFORMIN HCL 79 66 31 12
CLOPIDOGREL 76 65 32 36
LEVOFLOXACIN 75 61 33 117
FLUTICASONE PROPIONATE 74 67 34 40
ALLOPURINOL 72 58 35 22
POTASSIUM CHLORIDE 71 64 36 15
ATORVASTATIN CALCIUM 70 47 37 13
CARBIDOPA-LEVODOPA 70 67 37 77
NOVOLOG 70 59 37 93
TAMSULOSIN HCL 69 60 40 27
IPRATROPIUM-ALBUTEROL 68 61 41 101
LOSARTAN POTASSIUM 67 65 42 16
VENLAFAXINE HCL ER 65 37 43 84
ALENDRONATE SODIUM 64 58 44 20
ADVAIR DISKUS 60 50 45 31
HEPARIN SODIUM 58 58 46 253
CYMBALTA 57 32 47 75
TRAZODONE HCL 57 27 47 45
PLAVIX 56 46 49 55
FAMOTIDINE 55 53 50 74
LEVETIRACETAM 54 39 51 97
QUETIAPINE FUMARATE 53 43 52 69
BACLOFEN 53 21 52 111
KLOR-CON M10 52 52 54 122
DIOVAN 52 50 54 38
DILTIAZEM HCL 50 50 56 196
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.